![James D. Luterman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James D. Luterman
Keine laufenden Positionen mehr
Profil
James D.
Luterman worked as the Executive Vice President-Research & Development at OvaScience, Inc. from 2016 to 2018.
He received his undergraduate degree from Bucknell University and his doctorate degree from Rutgers State University of New Jersey.
Ehemalige bekannte Positionen von James D. Luterman
Unternehmen | Position | Ende |
---|---|---|
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von James D. Luterman
Bucknell University | Undergraduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |